|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-11-30
|
|
pubmed:abstractText |
A variety of regimens continue to be used in the treatment of Graves' disease with antithyroid drugs. We have investigated the factors which determine the initial response to methimazole (time until euthyroidism is achieved) in Graves' disease.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
257-63
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7586593-Adult,
pubmed-meshheading:7586593-Antithyroid Agents,
pubmed-meshheading:7586593-Drug Therapy, Combination,
pubmed-meshheading:7586593-Female,
pubmed-meshheading:7586593-Graves Disease,
pubmed-meshheading:7586593-Humans,
pubmed-meshheading:7586593-Iodides,
pubmed-meshheading:7586593-Male,
pubmed-meshheading:7586593-Methimazole,
pubmed-meshheading:7586593-Thyroxine,
pubmed-meshheading:7586593-Triiodothyronine
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Response to methimazole in Graves' disease. The European Multicenter Study Group.
|
|
pubmed:affiliation |
Department of Clinical Endocrinology, University of Essen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
